Market Tracker

04/21 10:42am ET

Impax Laboratories Inc (NASDAQ:IPXL)

24.75
Real-Time Quote
 +0.83 / +3.47%
Today’s Change
16.09
Today|||52-Week Range
28.50
-1.55%
Year-to-Date

Today’s Trading

Previous close23.92
Today’s open24.25
Day’s range24.25 - 25.79
Volume713,084
Average volume (3 months)621,604
Market cap$1.7B
Dividend yield--
Data as of 10:27am ET, 04/21/2014

Growth & Valuation

Earnings growth (last year)+79.27%
Earnings growth (this year)-10.08%
Earnings growth (next 5 years)+34.00%
Revenue growth (last year)-12.07%
P/E ratio17.0
Price/Sales3.29
Price/Book2.10

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co+0.23+0.94%
RAREUltragenyx Pharmaceu...-1.39-3.27%
ACORAcorda Therapeutics ...+0.11+0.31%
ACADACADIA Pharmaceutica...-0.16-0.82%
Data as of 10:42am ET, 04/21/2014

Financials

Next reporting dateMay 2, 2014
EPS forecast (this quarter)$0.05
Annual revenue (last year)$511.5M
Annual profit (last year)$101.3M
Net profit margin19.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Chung-Chiang Hsu
Chief Financial Officer &
Senior Vice President
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts